# Elixir Pharmaceuticals, Inc. — Form D

Elixir Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-28. The offering totals $25.0M, of which $12.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2009-05-28
- Form: D
- Accession: 0001175784-09-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $25.0M
- Amount sold: $12.0M
- Remaining: $13.0M
- Minimum investment: $1
- Investors: 36
- Date of first sale: 2009-05-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-44911

## Issuer

- Name: Elixir Pharmaceuticals, Inc.
- CIK: 0001175784
- Entity type: Corporation
- Jurisdiction: DE
- Address: 12 EMILY STREET, CAMBRIDGE, MA, 02139
- Phone: 617-995-7000

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Vernon Cassin | Director | Cambridge, MA |
| Ansbert Gadicke | Director | Morristown, NJ |
| Kenneth Greenberg | Director | South San Francisco, CA |
| Vaughn M Kailian | Director | Boston, MA |
| DION MADSEN | Director | VANCOUVER, A1 |
| Paul M Martha | Director | Cambridge, MA |
| Peter S DiStefano | Executive Officer | Cambridge, MA |
| Robert Kriebel | Executive Officer | Cambridge, MA |
| Paul M Martha | Executive Officer | Cambridge, MA |
| Karen Roberts | Executive Officer | Cambridge, MA |

## More

- [CIK 1175784 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1175784&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001175784-09-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.